Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below 12 months to the week close of 2026-10-23

Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Feb. 2, 2026 AVBP A 130,000 · · 130,000 Direct · Acquired
Feb. 3, 2025 AVBP A 102,000 · · 102,000 Direct · Acquired
Feb. 23, 2023 SYRE A 500,000 · · 500,000 Direct · Acquired
Aug. 23, 2022 SYRE A 130,000 · · 130,000 Direct · Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Feb. 2, 2026 AVBP Stock Option (right to buy) Common Stock (130,000) $22.67 Feb. 2, 2036 130,000 Acquired
Feb. 3, 2025 AVBP Stock Option (right to buy) Common Stock (102,000) $27.56 Feb. 3, 2035 102,000 Acquired
Feb. 23, 2023 SYRE Employee Stock Option (right to buy) Common Stock (500,000) $0.44 Feb. 22, 2033 500,000 Acquired
Aug. 23, 2022 SYRE Employee Stock Option (right to buy) Common Stock (130,000) $0.68 Aug. 22, 2032 130,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 6 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Jan. 25, 2024 AVBP Common Stock · Direct
Jan. 25, 2024 AVBP Stock Option (right to buy)→ Common Stock · Direct
Jan. 25, 2024 AVBP Stock Option (right to buy)→ Common Stock · Direct
Aug. 25, 2022 SYRE Common Stock 4,000 Direct
Aug. 25, 2022 SYRE Employee Stock Option (right to buy)→ Common Stock (130,000) 130,000 Direct
Aug. 25, 2022 SYRE Employee Stock Option (right to buy)→ Common Stock (85,000) 85,000 Direct

Compensation (DEF 14A)

10

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $443,943 · · · $155,694 · $12,200 $865,785

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.